Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 65 and up

Essential amino acid supplementation for patients with femoral fractures

Official title: MEND Repair & Recover Clinical Trial

Run by University of Iowa · NCT06050668 · Data updated 2026-11-12

This study is testing if taking essential amino acids for four weeks after surgery can help people with femoral fractures recover better and keep their muscle strength.

More Muscle Atrophy trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages65 Years and up
SexAll
Enrollment60 (estimated)
SponsorUniversity of Iowa
Academic / other
Locations2 sites (Iowa City, Iowa and 1 other locations)
StatusRecruiting
StartedJune 17, 2024
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedOctober 7, 2026
Trial IDNCT06050668 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are hospital inpatients aged 65 and older who have sustained a low-energy femoral fracture and are indicated for surgical fixation.

Probably not a fit

Patients who are non-ambulatory prior to injury or have cognitive impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the effects of a 4-week postoperative essential amino acid (EAA) supplementation on muscle health following femoral fragility fractures. Participants will be randomly assigned to receive either standard care or EAA-based supplementation, with assessments conducted over a 6-month period. The study aims to measure changes in muscle morphology, metabolic activity, inflammation, and physical performance, utilizing muscle biopsies and body composition analysis. The goal is to determine if EAA supplementation can enhance recovery and preserve muscle mass after surgery.

Why it matters

Potential benefit: If successful, this approach could significantly improve recovery outcomes and muscle health for patients recovering from femoral fractures.

How similar studies have gone: While the specific approach of EAA supplementation post-fracture is novel, similar studies have shown positive outcomes in muscle recovery and health in other contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Hospital inpatient
* Age ≥ 65 years old on admission
* Low-energy mechanism of injury
* Diagnosis of femur fracture (OTA 31, 32, or 33 fracture)
* Indicated for surgical fixation
* Able to provide informed consent

Exclusion Criteria:

* Part of a vulnerable population (ex: Incarcerated, Non-English speaking)
* Cognitive impairment (MMSE score ≤ 17)
* Electrical medical implant (ex: Pacemaker/Defibrillator, Left Ventricular Assist Device, Cochlear implant, Insulin pump, Pain medication pumps, Spinal cord stimulator)
* Non-ambulatory prior to injury
* Inability to consume an oral diet or allergy to supplement ingredients (ex: milk allergy)
* Concern for inability to complete follow-up
* Hemi or total arthroplasty (joint replacement)
* Patients with a historical diagnosis of chronic kidney disease (CKD)

Where it's running

  • University of Iowa Health Care
    Iowa City, Iowa, United States
    Recruiting
  • Slocum Center for Orthopedics & Sports Medicine
    Eugene, Oregon, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Protein boost during the luteal phase to help protect muscle

    This study tests whether increasing daily protein intake by 12% during the luteal phase can help prevent muscle breakdown in premenopausal women aged 18–35.

    Recruiting Sam Houston State University · Conroe, Texas and 1 other locations · NCT07843095

  • Digital lifestyle platform after rehabilitation to support self-management

    A digital, patient-facing platform is being tested to see if people who recently finished inpatient rehabilitation will use it and benefit from personalized lifestyle guidance at home.

    Recruiting at 2 sites Insel Gruppe AG, University Hospital Bern · Bern, Canton of Bern and 1 other locations · NCT07597031

  • See how well iFuse TORQ TNT works for pelvic fragility fractures

    This study tests the iFuse TORQ TNT implant in older adults with pelvic fragility fractures to see if real-world use leads to better outcomes.

    Recruiting at 3 sites SI-BONE, Inc. · Edina, Minnesota and 2 other locations · NCT07530497

  • Postoperative NMES on both thighs with protein during abdominal cancer surgery

    This study tests whether neuromuscular electrical stimulation of both thighs after major abdominal cancer surgery helps preserve leg muscle, and whether adding protein drinks improves the effect.

    Recruiting University of Nottingham · Derby, Derbyshire · NCT06964438

  • Improving outcomes for patients with fragility fractures

    This study is testing if a new support program for older adults with recent bone fractures can help them recover better than standard care that just provides education.

    Recruiting at 23 sites University of Alabama at Birmingham · Birmingham, Alabama and 22 other locations · NCT06455085

  • Assessing muscle thickness changes in heart failure patients

    This study is testing how muscle thickness changes in heart failure patients receiving advanced treatments like heart transplants or assist devices to see how it affects their recovery.

    Recruiting Tufts Medical Center · Boston, Massachusetts · NCT06253104

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.